[1] |
HU, F., ROSENBERGER, W. F. and ZHANG, L.-X. (2006). Asymptotically best response-adaptive randomization procedures. J. Statist. Plann. Inference 136 1911-1922. · Zbl 1113.62089 · doi:10.1016/j.jspi.2005.08.011 |
[2] |
IVANOVA, A. and HOBERMAN, S. (2015). Higher order response-adaptive urn designs for clinical trials with highly successful treatments. J. R. Stat. Soc. Ser. C. Appl. Stat. 64 175-189. · doi:10.1111/rssc.12066 |
[3] |
KORN, E. L. and FREIDLIN, B. (2011). Outcome-adaptive randomization: Is it useful? J. Clin. Oncol. 29 771-776. · doi:10.1200/JCO.2010.31.1423 |
[4] |
MILES, L. F., BURT, C., ARROWSMITH, J., MCKIE, M. A., VILLAR, S. S., GOVENDER, P. and FALTER, F. (2021). Optimal protamine dosing after cardiopulmonary bypass: The PRODOSE adaptive randomised controlled trial. PLoS Med. 18 e1003658. |
[5] |
PROPER, J. and MURRAY, T. A. (2022). An alternative metric for evaluating the potential patient benefit of response-adaptive randomization procedures. Biometrics. To appear. |
[6] |
PROSCHAN, M. and EVANS, S. (2020). Resist the temptation of response-adaptive randomization. Clin. Infect. Dis. 71 3002-3004. |
[7] |
ROSENBERGER, W. F. (1996). New directions in adaptive designs. Statist. Sci. 11 137-149. |
[8] |
VILLAR, S. S. and ROSENBERGER, W. F. (2018). Covariate-adjusted response-adaptive randomization for multi-arm clinical trials using a modified forward looking Gittins index rule. Biometrics 74 49-57. · Zbl 1415.62141 · doi:10.1111/biom.12738 |
[9] |
XIAO, Y., LIU, Z. and HU, F. (2017). Bayesian doubly adaptive randomization in clinical trials. Sci. China Math. 60 2503-2514. · Zbl 1414.62342 · doi:10.1007/s11425-016-0056-1 |
[10] |
ZHANG, L.-X., HU, F., CHEUNG, S. H. and CHAN, W. S. (2007). Asymptotic properties of covariate-adjusted response-adaptive designs. Ann. Statist. 35 1166-1182 · Zbl 1118.62124 · doi:10.1214/009053606000001424 |